Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Community Acquired Pneumonia: Outcome, Quality of Life and Immune Status
2013-002166-39Phase 4Active
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Sep 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of pneumococcal 13-valent conjugate vaccine in community acquired pneumonia (CAP) and pneumococcal disease (2 arms), sponsored by St. Antonius Ziekenhuis. Primary endpoint: Primary antibody response. Started Sep 2013; status: active.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
community acquired pneumonia (CAP)pneumococcal disease
Beyond the preview
Go deeper on 2013-002166-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002166-39.